Cargando…

Genome-wide identification of alternative splicing associated with histone deacetylase inhibitor in cutaneous T-cell lymphomas

Cutaneous T-cell lymphomas (CTCLs) are a kind of non-Hodgkin lymphoma that originates from skin, which is difficult to treat with traditional drugs. Human histone deacetylase inhibitors (HDACi) targeted therapy has become a promising treatment strategy in recent years, but some patients can develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shirong, Zhang, Jingzhan, Ding, Yuan, Kang, Xiaojing, Pu, Xiongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485882/ https://www.ncbi.nlm.nih.gov/pubmed/36147491 http://dx.doi.org/10.3389/fgene.2022.937623

Ejemplares similares

Histone Deacetylase Activity Modulates Alternative Splicing
por: Hnilicová, Jarmila, et al.
Publicado: (2011)

Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients
por: Dai, Zhibing, et al.
Publicado: (2023)

Genome-Wide Identification of Immune-Related Alternative Splicing and Splicing Regulators Involved in Abdominal Aortic Aneurysm
por: Wu, Shiyong, et al.
Publicado: (2022)

Histone deacetylase inhibitors in Hodgkin lymphoma
por: Buglio, Daniela, et al.
Publicado: (2010)

Comprehensive Identification and Alternative Splicing of Microexons in Drosophila
por: Pang, Ting-Lin, et al.
Publicado: (2021)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone deacetylases modulate resistance to the therapy in lung cancer
por: Contreras-Sanzón, Estefanía, et al.
Publicado: (2022)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
por: Wells, Christina E., et al.
Publicado: (2013)

Sex-Dependent Effects of the Histone Deacetylase Inhibitor, Sodium Valproate, on Reversal Learning After Developmental Arsenic Exposure
por: Tyler, Christina R. Steadman, et al.
Publicado: (2018)

Genome-Wide Characterization of Alternative Splicing Events and Their Responses to Cold Stress in Tilapia
por: Li, Bi Jun, et al.
Publicado: (2020)

Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
por: Lu, Guang, et al.
Publicado: (2023)

Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma
por: Song, Jing, et al.
Publicado: (2021)

Genome-wide analysis of dysregulated RNA-binding proteins and alternative splicing genes in keloid
por: Zhu, Zhen, et al.
Publicado: (2023)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
por: Psilopatis, Iason, et al.
Publicado: (2021)

Genome-Wide Identification of Histone Modifications Involved in Placental Development in Pigs
por: Han, Kun, et al.
Publicado: (2019)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma
por: Abe, Fumito, et al.
Publicado: (2016)

Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
por: Xiong, Yongfu, et al.
Publicado: (2020)

Comprehensive Analysis of Cell Population Dynamics and Related Core Genes During Vitiligo Development
por: Zhang, Jingzhan, et al.
Publicado: (2021)

Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor
por: Gleason, Laura, et al.
Publicado: (2022)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Genome-Wide Analysis of Alternative Splicing Provides Insights Into Stress Response of the Pacific White Shrimp Litopenaeus vanname
por: Zhang, Xiaoxi, et al.
Publicado: (2019)

Genome-Wide Analysis for the Regulation of Gene Alternative Splicing by DNA Methylation Level in Glioma and its Prognostic Implications
por: Yang, Zeyuan, et al.
Publicado: (2022)

Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
por: Marquard, L, et al.
Publicado: (2008)

Genome-wide Identification and Analysis of Splicing QTLs in Multiple Sclerosis by RNA-Seq Data
por: He, Yijie, et al.
Publicado: (2021)

Histone Deacetylase 11 Knockdown Blocks Larval Development and Metamorphosis in the Red Flour Beetle, Tribolium castaneum
por: George, Smitha, et al.
Publicado: (2020)

Getting a GRP on histone deacetylase inhibitor selectivity
por: Ding, Husheng, et al.
Publicado: (2017)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

Clinical Toxicities of Histone Deacetylase Inhibitors
por: Subramanian, Srividya, et al.
Publicado: (2010)

Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006)

Histone Deacetylase Inhibitors as Anticancer Drugs
por: Eckschlager, Tomas, et al.
Publicado: (2017)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

Transcriptome-Wide Analyses Identify Dominant as the Predominantly Non-Conservative Alternative Splicing Inheritance Patterns in F1 Chickens
por: Qi, Xin, et al.
Publicado: (2021)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r1o30e853rp67ikgde0bdq6s9k